Cite
Huang KL, Li S, Mertins P, et al. Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017;8:15479doi: 10.1038/ncomms15479.
Huang, K. L., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., Mani, D. R., Clauser, K. R., Tanioka, M., Usary, J., Kavuri, S. M., Xie, L., Yoon, C., Qiao, J. W., Wrobel, J., Wyczalkowski, M. A., Erdmann-Gilmore, P., Snider, J. E., Hoog, J., Singh, P., Niu, B., Guo, Z., Sun, S. Q., Sanati, S., Kawaler, E., Wang, X., Scott, A., Ye, K., McLellan, M. D., Wendl, M. C., Malovannaya, A., Held, J. M., Gillette, M. A., Fenyö, D., Kinsinger, C. R., Mesri, M., Rodriguez, H., Davies, S. R., Perou, C. M., Ma, C., Townsend, R. R., Chen, X., Carr, S. A., Ellis, M. J., & Ding, L. (2017). Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature communications, 815479. https://doi.org/10.1038/ncomms15479
Huang, Kuan-Lin, et al. "Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts." Nature communications vol. 8 (2017): 15479. doi: https://doi.org/10.1038/ncomms15479
Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L. Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479. PMID: 28440318; PMCID: PMC5414030.
Copy
Download .nbib